Doctor of Philosophy in Genome Science and Technology (PhD)
The Genome Science and Technology graduate program is a trans-disciplinary program that combines genomic research with leading-edge technology development in genome sciences for students pursing an M.Sc. or Ph.D. This program is intended to accommodate the diverse background of students and the broad nature of genomic research in human, animal, plant, microbes, and viruses.
- Generate a culture of innovation and discovery by exposing trainees at all levels to important and timely scientific problems being addressed using emerging technologies.
- Enable researchers to effectively work at the nexus of biology, engineering, and physical sciences by providing a unified training program including joint seminars, cross-disciplinary rotations, and hands-on training in new technology and methodology.
- Provide enriching professional development programs to assist the transition of trainees into both the academic and industrial workforces.
- Foster close interactions, collaborations, and intellectual exchange with other laboratories nationally and internationally.
Our goal is to be among the top 10 graduate programs in genome sciences & technology in North America.
What makes the program unique?
The Ph.D. program in Genome Science and Technology (GSAT) incorporates an innovative rotation program that allows students to access multiple highly skilled research faculty during their graduate program. These rotation opportunities allow student to learn the latest advances in genomic sciences and high through-put technologies. Rotations also allow valuable relationships to form for future collaborative opportunities.
The GSAT program has collaborative associations with both the Centre for High Through-put Technology and the Michael Smith Laboratories. Faculty members associated with the program have diverse backgrounds in genomics and proteomics, bio-engineering, systems biology, chemical biology,device and instrumentation development, and engineering.
Systems biology, Genomics and proteomics, Chemical biology, Bioengineering, Device and instrumentation development, Computational biology
GSAT faculty are spread throughout the UBC campus, with most occupying the Michael Smith Laboratories building. A small number of GSAT faculty may reside off-campus at the BC Cancer Research Centre or hospital research labs and Institutions.
Students who are selected for the GSAT rotation scholarship will not need to secure a supervisor before they are enrolled in the program. All other students must secure a supervisor before they can be admitted into the program. As well, they must meet the minimum admission requirements set out by Graduate and Post-doctoral Studies at UBC.
CV, Official transcripts, three letters of reference, Official English exam scores (if required)
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
Supervisor commitment required prior to application?
Prior degree requirements
Applicants must have a Life-Sciences degree, with significant experience in a quantitative science OR a Computer Science/Math/Engineering/Physics degree with significant experience in Life Sciences. Although work experience may be taken into consideration if the degree is outside these areas.
All students accepted by a faculty member and enrolled in the program will be paid a minimum stipend of $22,000/year. Students who have been selected for the GSAT rotation scholarships will also have their tuition paid for the first two years of study.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,632.61||$2,868.22|
|Tuition per year||$4,897.83||$8,604.66|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$923.38 (approx.)|
|Costs of living (yearly)||starting at $16,884.10 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
Adams, Keith (Molecular evolution, genome evolution, and gene expression)
Andersen, Raymond (Chemicals produced by marine organisms)
Aparicio, Samuel (Breast cancer, genome sequencing )
Birol, Inanc (bioinformatics, computational biology, genomics, transcriptome analysis, next generation sequencing, cancer, Bioinformatics, sequence assembly, transcriptomics, gene regulation networks, high throughput informatics for big data)
Bohlmann, Jorg (plant biochemistry, forestry genomics, forest health, conifers, poplar, bark beetle, mountain pine beetle, natural products, secondary metabolites, terpenes, floral scent, grapevine, Conifer genomics Forest health genomics Mountain pine beetle, fungus, pine interactions and genomics Chemical ecology of conifer, insect interactions)
Bouchard-Cote, Alexandre (machine/statistical learning; mathematical side of the subject as well as in applications in linguistics and biology)
Brown, Carolyn Janet (Gene Regulation and Expression, Chromosomes: Structure / Organization, Epigenetic control of gene expression, X-chromosome inactivation, Long non-coding RNAs, XIST RNA, Genes escaping X-chromosome inactivation, DNA methylation)
Brumer, Harry (Biological and Biochemical Mechanisms, Chemical Synthesis and Catalysis, enzymes, polysaccharides, carbohydrates, biomass, cellulose, plant cell walls, microbiota)
Bryan, Jennifer Frazier (Statistics, Genomics and Experimental Evolution , Prostate cancer)
Collins, Colin (translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics)
Conibear, Elizabeth (Molecular Genetics, Cell Signaling and Cancer, Genomics and Proteomics, Neurodegenerative Diseases, Membranes, Enzymes and Proteins, Parkinson's Disease, Protein Palmitoylation, Vesicle Trafficking)
Cote, Helene (HIV Infection, blood research, infectious diseases)
Cullis, Pieter (Molecular biology for therapeutic purposes, lipids, immunological drugs)
Eltis, Lindsay (Microbiology, Enzymes and Proteins, Metabolism (Living Organisms), Bacterial catabolism of steroids and lignin, Mycobacterium tuberculosis, biocatalyst development)
Farrer, Matthew (Neurological Diseases, Genetics of Neurological and Psychiatric Diseases, Neuronal Modeling, Neuronal Communication and Neurotransmission, Parkinson's disease, Dementia, Epilepsy)
Finlay, B Brett (Infectious agents, bacteria, microbial infections and how humans react to it)
Foster, Leonard (Biotechnology, Bioinformatics, Biological and Biochemical Mechanisms, Microbiology, Cell Signaling and Infectious and Immune Diseases, Immune System, Agriculture, Proteomics, honey bees, host-pathogen interactions, antigen presentation, systems biology)
Friedman, Jan Marshall (Application of whole genome sequencing to diagnose genetic disease, Clinical genomics, Neurofibromatosis, Birth defects epidemiology)
Gsponer, Joerg (Protein-DNA, protein-RNA and protein-protein interactions)
Hallam, Steven (methanogenesis, methane oxidation, methyl coenzyme M reductase, metagenomics, environmental microbiology, genomics, proteomics, microbial ecology, systems biology, archaea, energy, bioinformatics, Microbial communities, construction and interpretation of environmental genomic libraries, generation of computational tools and workflows for taxonomic and functional binning, population genome assembly, and comparative community analysis, development and functional screens to interrogate environmental genomic libraries for bioactive small molecules and biocatalysis)
Hancock, Robert E (Cationic Antimicrobial Peptides, Host Defence Peptides and Innate Immunity, Functional Genomics of Pseudomonas aeruginosa, Regulation of Antibiotic Resistance, Array Data, Self-promoted uptake hypothesis)
Haney, Cara (genetic and metabolic factors that regulate assembly of host-associated microbial communities ()
Hansen, Carl (Single-Cell Analysis, Molecular Diagnostics, genomics)
Haynes, Charles (Protein purification, recombinant proteins, molecular thermodynamics, biocompatible polymers)
Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
Recent Doctoral Citations
- Dr. Kevin Andrew Mehr
"Dr. Mehr developed screening technologies to search the human gut for sugar-modifying enzymes. He discovered numerous enzymes capable of building or breaking down complex biochemicals. This included the discovery of an enzyme capable of converting the blood type A antigen into blood type O, rendering it as universally donatable blood." (May 2017)
- Dr. Sophie Amelia Catherine Comyn
"How do changes to protein quality control networks perturb proteostasis - a process required for cell viability? To address this question Dr. Comyn established a flow cytometry based screen to identify factors involved in proteostasis. This work provides a valuable resource for future studies of protein quality control and protein stability." (May 2017)
- Dr. Keith Andrew Mewis
"Dr. Mewis developed a technique for the identification of bacterial enzymes capable of degrading plant matter. He used it to study the order in which wood is degraded as it moves through the digestive tract of the beaver. The results allowed for a new sub-classification system for these enzymes, which will help to improve biofuel technologies." (May 2017)
- Dr. Florian Baier
"Dr. Baier investigated the evolutionary divergence of enzyme functions. He revealed that many enzymes have an intrinsic evolutionary potential that is shaped by environmental and biophysical constraints. His research provides insight into the molecular basis of adaptation and will help with the design and engineering of proteins with desired properties." (May 2017)
- Dr. Helen Louise Lund
"The emergence of personalized medicine, due to advances in genomics and proteomics, has created a clinical demand for increasingly specific diagnostic testing. Dr. Lund developed and validated 2 such tests, aimed at specific forms of both leukemia and lung cancer. This unique approach has the potential to directly impact cancer diagnostics." (May 2016)